HIV	Human immunodeficiency virus
SSA	Sub-Saharan Africa
HIV-1C	Human immunodeficiency virus type 1 subtype C
ART	Antiretroviral therapy
LMICs	Low- and middle-income countries
PWH	People with HIV
HIV-1B	Human immunodeficiency virus type 1 subtype B
RT	Reverse transcriptase
NRTIs	Nucleoside reverse transcriptase inhibitors
NNRTIs	Non-nucleoside reverse transcriptase inhibitors
NRTTIs	Nucleoside reverse transcriptase translocation inhibitors
RTIs	Reverse transcriptase inhibitors
RT-conn	Reverse transcriptase connection
RNase H	Ribonuclease H
DRMs	Drug resistance mutations
NVP	Nevirapine
DLV	Delavirdine
TN	Treatment-naïve
TE	Treatment-experienced
VF	Virologic failure
BCPP	Botswana Combination Prevention Project
EFV	Efavirenz
DTG	Dolutegravir
NGS	Next-generation sequencing
RNA	Ribonucleic acid
DNA	Deoxyribonucleic acid
VL	Viral load
VS	Virally suppressed
MSA	Multiple-sequence alignment
IQRs	Interquartile ranges